5 Takeaways From Becton, Dickinson and Company’s $24 Billion Acquisition Of C.R. Bard

Another week, another ginormous medical device deal. This time it is Becton Dickinson which has acquired C.R. Bard in a $24 billion deal to extend its product footprint in the latest of many medical device acquisitions that are reshaping the manufacturing landscape.

Back to news